Furthermore, lowering expression of MMP-9 or inhibiting its function using an MMP-9 inhibitor reduced the invasiveness of CLL cells, indicating the capacity of Wnt5a/ROR1-signaling to enhance invasiveness of CLL cells is dependent on MMP-9. This evidence concerns the gene ROR1 and B-cell chronic lymphocytic leukemia.